Teva Pharmaceutical Industries EPS - Earnings per Share 2010-2024 | TEVA

Teva Pharmaceutical Industries earnings per share (EPS) for the twelve months ending September 30, 2024 was $-0.84, a 60% decline year-over-year.

  • Teva Pharmaceutical Industries EPS for the quarter ending September 30, 2024 was $-0.39, a 750% decline year-over-year.
  • Teva Pharmaceutical Industries 2023 annual EPS was $-0.5, a 77.27% decline from 2022.
  • Teva Pharmaceutical Industries 2022 annual EPS was $-2.2, a 678.95% decline from 2021.
  • Teva Pharmaceutical Industries 2021 annual EPS was $0.38, a 110.44% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Teva Pharmaceutical Industries EPS - Earnings per Share 2010-2024 | TEVA

  • Teva Pharmaceutical Industries EPS for the quarter ending September 30, 2024 was $-0.39, a 750% decline year-over-year.
  • Teva Pharmaceutical Industries 2023 annual EPS was $-0.5, a 77.27% decline from 2022.
  • Teva Pharmaceutical Industries 2022 annual EPS was $-2.2, a 678.95% decline from 2021.
  • Teva Pharmaceutical Industries 2021 annual EPS was $0.38, a 110.44% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.